Case Report: Dysgeusia, Strawberry Tongue, and Psoriatic Eruptions after Combination Treatment with Adalimumab, Sulfasalazine, and Etoricoxib for Ankylosing Spondylitis

Binglin Cui ¹ Jing Lin ¹ Yuanchun Huang ¹ Huachen Zhu ² Jinbo Zou ¹ Jiesheng Qin ¹ Hui Pan ^3* Jian Chen ^1*

• ¹ First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong Province, China
• ² The University of Hong Kong, Pokfulam, Hong Kong, SAR China
• ³ College of Medicine, Shantou University, Shantou, China

Background: Tumor necrosis factor blockers can suppress immune system and lead to various adverse drug reactions, including deaths. We present a rare case of dysgeusia, strawberry tongue, and psoriasis-like eruptions after simultaneous administration of adalimumab, sulfasalazine, and etoricoxib. Case description: A 36-year-old male with ankylosing spondylitis presented with progressive loss of taste for three months and rashes on his upper trunk for five days. He had been receiving adalimumab, sulfasalazine, and etoricoxib for nine months. After self-discontinuing the medicines, the rashes gradually subsided. On examination, swollen and red strawberry tongue were noticed. Acinetobacter pittii was isolated by sputum culture. The patient refused any treatment. During follow-up, recurrent dispersed papules/macules and desquamation appeared on his upper trunk, with erythema and erosion in umbilical region. Subsequently, generalized scalp erythema, exudates, scabs, hair bundles, redness and desquamation behind ears occurred. The tongue, taste, and skin lesions resolved sequentially and steadily until complete recovery. Outcome: He remained in remission during three-year follow-up. The total course of disease was around ten months. Discussion: Clinicians should be cautious of the adverse drug reactions/events due to adalimumab, sulfasalazine, and etoricoxib. Rational use of medicines is advocated.